Yield10 Bioscience

Yield10 Bioscience, Inc. operates as an agricultural bioscience company. It focuses on the development of technologies to produce step-change improvements in crop yield for food and feed crops to enhance global food security. The company was founded by Anthony J. Sinskey, Simon F. Williams and Oliver P. Peoples in June 1992 and is headquartered in Woburn, MA.

Earnings data Q3 2020

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q3 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Yield10 Bioscience, Inc. is an agricultural bioscience company, which engages in the development of oilseed Camelina sativa as a platform crop for large scale production of low carbon sustainable seed products. The company was founded by Anthony J. Sinskey, Simon F. Williams, and Oliver P. Peoples in 1992 and is headquartered in Woburn, MA.

WOBURN, Mass., May 03, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its first quarter 2022 financial results and provide a corporate update on Wednesday, May 11, 2022.

Yield10 Bioscience to Announce First Quarter 2022 Financial Results and Host a Conference Call on Wednesday, May 11, 2022

WOBURN, Mass., April 27, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today named Willie Loh, Ph.D., as a special advisor to the Board of Directors and Management of the Company, effective immediately. Dr. Loh previously served as Vice President, Market Development, Global Edible Oils Division at Cargill Incorporated, the global food and agriculture company.

Yield10 Bioscience Names Willie Loh, Ph.D., Former Cargill Executive, as Special Commercial and Technical Advisor

Andersons

Bunge Global SA

Surging wheat prices could provide systemic support to many commodity stocks that have U.S. exposure. Here are three wheat stocks to buy.

Should You Buy Wheat Stocks? 3 Companies To Consider.

WOBURN, Mass., March 22, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that President and CEO Oliver Peoples, Ph.D. will participate at the Maxim Group 2022 Virtual Growth Conference, which is being held March 28-30, 2022.

Yield10 Bioscience to Present at the Maxim Group 2022 Virtual Growth Conference and Participate in Fireside Chat

-Establishing the Camelina crop as a replenishable reserve of feedstock oil for biofuels

Yield10 Bioscience Chief Executive Officer Dr. Oliver Peoples to Present on Development of Camelina Crop for Use in Biofuels at ABLC 2022 Conference

Yield10 Bioscience, Inc. (YTEN) CEO Oliver Peoples on Q4 2021 Results - Earnings Call Transcript

-Near-term commercial focus on the Renewable Diesel market

Yield10 Bioscience Announces Fourth Quarter and Full Year 2021 Financial Results

-Acre-scale seed production planned in spring 2022

Yield10 Bioscience Announces Recent Advances in the Development of Camelina as a Production Platform for PHA Bioplastic

Company is Scaling up Camelina Line E3902 Seed Production  and Developing Herbicide Tolerant Lines

Yield10 Bioscience Announces an Update on the Camelina Line E3902 Development Program for Producing Low-carbon Feedstock Oil for Renewable Diesel

WOBURN, Mass., March 02, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its fourth quarter and full year 2021 financial results and provide a corporate update on Wednesday, March 9, 2022.

Yield10 Bioscience to Announce Fourth Quarter and Full Year 2021 Financial Results and Host a Conference Call on Wednesday, March 9, 2022

Increasing Oil Content in Oilseed Crops is Required to Meet the Projected Demand for Renewable Diesel Increasing Oil Content in Oilseed Crops is Required to Meet the Projected Demand for Renewable Diesel

Yield10 Bioscience Field Test Results Show Seed Oil Content Increase in Camelina and Canola

Three Yield10 CRISPR Genome-Edited Camelina Lines Were Determined to be Similar to Conventional Camelina Varieties and Not Subject to Regulation Three Yield10 CRISPR Genome-Edited Camelina Lines Were Determined to be Similar to Conventional Camelina Varieties and Not Subject to Regulation

Yield10 Bioscience Receives Favorable Ruling from the Argentine Biosafety Commission (CONABIA) for Company's Camelina Lines

WOBURN, Mass., Jan. 25, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced the hiring of Darren Greenfield to serve as the Company's Senior Director of Seed Operations. In this newly created position, Mr. Greenfield will be responsible for Camelina seed scale up and commercial contract production. He brings over 25 years of experience with major agriculture companies managing the development and commercial production of proprietary canola plant varieties. He also brings experience with identity preserved supply chains for specialty products based on his work at Dow Agrosciences with high oleic canola oil. He joins Yield10 from BASF Canada, Inc.

Yield10 Bioscience Hires Darren Greenfield as Senior Director of Seed Operations

WOBURN, Mass., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, announced today that President and CEO Oliver Peoples, Ph.D. will give a corporate presentation at the H.C. Wainwright Bioconnect Investment Conference, which is being held virtually from January 10 – 13, 2022.

Yield10 Bioscience to Present at the H.C. Wainwright Bioconnect Virtual Conference

WOBURN, Mass., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that its Chief Science Officer Dr. Kristi Snell will present during the Canola Week 2021 Conference taking place in virtual format November 30 through December 2, 2021.

Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present on Advances in Utilizing CRISPR Genome Editing to Increase Seed Oil Content in Camelina at Canola Week Conference

Yield10 Bioscience, Inc. (YTEN) CEO Ollie Peoples on Q3 2021 Results - Earnings Call Transcript

Management will Host a Conference Call Today at 4:30 p.m. (ET) to Review Financial Results and Provide a Corporate Update Management will Host a Conference Call Today at 4:30 p.m. (ET) to Review Financial Results and Provide a Corporate Update

Yield10 Bioscience Announces Third Quarter 2021 Financial Results

Metabolix, Inc. (YTEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will Metabolix, Inc. (YTEN) Report Negative Q3 Earnings? What You Should Know

WOBURN, Mass., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that the Company will report its third quarter 2021 financial results and provide a corporate update on Wednesday, November 10, 2021.

Yield10 Bioscience to Announce Third Quarter 2021 Financial Results and Host a Conference Call on Wednesday, November 10, 2021

WOBURN, Mass., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, announced today that President and CEO Oliver Peoples, Ph.D. will present at the Maxim Group Global AgTech Conference, which is being held virtually on October 14, 2021.

Yield10 Bioscience to Participate in Maxim Group AgTech Virtual Conference

WOBURN, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, announced today that President and CEO Oliver Peoples, Ph.D. will give a corporate presentation at the H.C. Wainwright 23rd Annual Global Investment Conference, which is being held virtually from September 13 – 15, 2021.

Yield10 Bioscience to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Yield10 Bioscience, Inc. (YTEN) CEO Oliver Peoples on Q2 2021 Results - Earnings Call Transcript

Metabolix, Inc. (YTEN) delivered earnings and revenue surprises of -20.75% and -17.14%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Metabolix, Inc. (YTEN) Reports Q2 Loss, Lags Revenue Estimates

Management will Host a Conference Call Today at 4:30 p.m. (ET) to Review

News for Yield10 Bioscience Stock (YTEN)